OUTCOMES OF EXTERNAL-BEAM RADIATION-THERAPY FOR PROSTATE-CANCER - A STUDY OF MEDICARE BENEFICIARIES IN 3 SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS AREAS
Fj. Fowler et al., OUTCOMES OF EXTERNAL-BEAM RADIATION-THERAPY FOR PROSTATE-CANCER - A STUDY OF MEDICARE BENEFICIARIES IN 3 SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS AREAS, Journal of clinical oncology, 14(8), 1996, pp. 2258-2265
Purpose: This study was designed to obtain representative estimates of
the quality of life and probabilities of possible adverse effects amo
ng Medicare-age patients treated with external-beam radiation therapy
for prostate cancer, Methods: patients treated for local or regional p
rostate cancer with high-energy external-beam radiation between 1989 a
nd 1991 were sampled from a claims data bose of the Surveillance, Epid
emiology, and End Results (SEER) program from three regions, Patients
were surveyed primarily by moil, with telephone follow-up evaluation o
f nonrespondents, There were 621 respondents (83% response rate), The
results were compared with data from a previously published national s
urvey of Medicare-age men who had undergone radical prostatectomy. Res
ults: Although they were older at the time of treatment, radiation pat
ients were less likely than surgical patients to wear pads for wetness
(7% v 32%) and had a lower rate of impotence (23% v 56% for men < 70
years), while they were more likely to report problems with bowel dysf
unction (10% v 4%), Both groups reported generally positive feelings a
bout their treatments, Radiation and surgical patients reported simila
r rates of additional subsequent treatment (24% v 26% at 3 years after
primary treatment), However, radiation patients were less likely to s
ay they were cancer-free, and they reported more worry about cancer th
an did surgical patients, Conclusion: The health-related quality of li
fe of radiation and surgical patients, on average, is similar, but the
pattern of experience with adverse consequences of treatment differs
by treatment. (C) 1996 by American Society of Clinical Oncology.